 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
The Effect of Diet and Exercise or Metformin on the Metabolic Syndrome
19 April 2005 | Volume 142 Issue 8 | Page I-46
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial." It is in the 19 April 2005 issue of Annals of Internal Medicine (volume 142, pages 611-619). The authors are T.J. Orchard, M. Temprosa, R. Goldberg, S. Haffner, R. Ratner, S. Marcovina, and S. Fowler, for the Diabetes Prevention Program Research Group.
What is the problem and what is known about it so far?
The metabolic syndrome is a condition in which people have at least 3 of the following abnormalities: overweight, high blood pressure, high triglyceride levels (a bad type of fat in the blood), low high-density lipoprotein cholesterol levels ("good"cholesterol), and high blood sugar levels. People with the metabolic syndrome are at high risk for developing type 2 diabetes and cardiovascular disease, including heart attack and stroke. Type 2 diabetes (adult-onset diabetes) interferes with the body's ability to store energy from food. The result is high blood levels of sugar. Many people with type 2 diabetes have slightly high levels of blood sugar for years before reaching diabetes levels, a condition sometimes called pre-diabetes. A large study showed 2 ways to prevent or delay the development of diabetes in people with pre-diabetes. The first is a diet and exercise program for weight loss. The other is a small daily dose of a diabetes medication called metformin. It is unknown whether these treatments might also prevent or reverse the metabolic syndrome.
Why did the researchers do this particular study?
To see whether diet and exercise or metformin prevents or reverses the metabolic syndrome in people with high blood sugar levels (impaired glucose tolerance).
Who was studied?
3234 patients from a large study that assigned patients with pre-diabetes to diet and exercise, metformin, or neither.
How was the study done?
The researchers categorized patients as having the metabolic syndrome if they had at least 3 of the following: large waist size, low good cholesterol level, high triglyceride level, high blood pressure, or high fasting blood sugar. For patients who did not have the metabolic syndrome at the start of the study, the researchers determined whether those who received the diet and exercise program or metformin were less likely to develop the metabolic syndrome over the course of the study than those who did not receive these treatments. For patients who already had the metabolic syndrome at the start of the study, the authors determined whether those who got one of the treatments were more likely to no longer have the syndrome at the end of the study than patients who did not get these treatments.
What did the researchers find?
Over half of the patients had the metabolic syndrome at the start of the study. Diet and exercise or metformin each prevented the development of the metabolic syndrome in patients who did not have it at the start of the study. Patients who had the syndrome at the start of the study were more likely to be free of it at the end if they received a diet and exercise intervention or metformin than if they received neither. The benefit of the diet and exercise program was larger than the benefit of metformin.
What were the limitations of the study?
The study included only people with impaired glucose tolerance, so it might not apply to people with normal blood sugar. The study was also too short to see whether the reduction in the metabolic syndrome led to fewer cardiovascular events.
What are the implications of the study?
Diet and exercise or metformin can reduce the metabolic syndrome in people with high blood sugar.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  Z. T. Bloomgarden American College of Endocrinology Pre-Diabetes Consensus Conference: Part One Diabetes Care, October 1, 2008; 31(10): 2062 - 2069. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Rosenzweig, E. Ferrannini, S. M. Grundy, S. M. Haffner, R. J. Heine, E. S. Horton, and R. Kawamori Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3671 - 3689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K.-T. Li, B. C.-H. Kwan, C. C. Szeto, and G. T.-C. Ko Metabolic syndrome in peritoneal dialysis patients NDT Plus, August 1, 2008; 1(4): 206 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Kumanyika, E. Obarzanek, N. Stettler, R. Bell, A. E. Field, S. P. Fortmann, B. A. Franklin, M. W. Gillman, C. E. Lewis, W. C. Poston II, et al. Population-Based Prevention of Obesity: The Need for Comprehensive Promotion of Healthful Eating, Physical Activity, and Energy Balance: A Scientific Statement From American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (Formerly the Expert Panel on Population and Prevention Science) Circulation, July 22, 2008; 118(4): 428 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R Desilets, S. Dhakal-Karki, and K. C Dunican Role of Metformin for Weight Management in Patients Without Type 2 Diabetes Ann. Pharmacother., June 1, 2008; 42(6): 817 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S Wierzbicki, S. D Purdon, T. C Hardman, R. Kulasegaram, and B. S Peters Review: Clinical aspects of the management of HIV lipodystrophy The British Journal of Diabetes & Vascular Disease, May 1, 2008; 8(3): 113 - 119. [Abstract] [PDF]
|
|
|
|
|
|
D. Giugliano, A. Ceriello, and K. Esposito Mediterranean Diet Inversely Associated With the Incidence of Metabolic Syndrome: the SUN Prospective Cohort: Response to Tortosa et al. Diabetes Care, May 1, 2008; 31(5): e36 - e36. [Full Text] [PDF]
|
|
|
|
|
|
P. Ilanne-Parikka, J. G. Eriksson, J. Lindstrom, M. Peltonen, S. Aunola, H. Hamalainen, S. Keinanen-Kiukaanniemi, M. Laakso, T. T. Valle, J. Lahtela, et al. Effect of Lifestyle Intervention on the Occurrence of Metabolic Syndrome and its Components in the Finnish Diabetes Prevention Study Diabetes Care, April 1, 2008; 31(4): 805 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Mather, T. Funahashi, Y. Matsuzawa, S. Edelstein, G. A. Bray, S. E. Kahn, J. Crandall, S. Marcovina, B. Goldstein, R. Goldberg, et al. Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program Diabetes, April 1, 2008; 57(4): 980 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hu, J. Lindstrom, P. Jousilahti, M. Peltonen, L. Sjoberg, R. Kaaja, J. Sundvall, and J. Tuomilehto The Increasing Prevalence of Metabolic Syndrome among Finnish Men and Women over a Decade J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 832 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Despres, P. Poirier, J. Bergeron, A. Tremblay, I. Lemieux, and N. Almeras From individual risk factors and the metabolic syndrome to global cardiometabolic risk Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B24 - B33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bianchi, R. Miccoli, G. Penno, and S. Del Prato Primary Prevention of Cardiovascular Disease in People With Dysglycemia Diabetes Care, February 1, 2008; 31(Supplement_2): S208 - S214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Giugliano, A. Ceriello, and K. Esposito Are there specific treatments for the metabolic syndrome? Am. J. Clinical Nutrition, January 1, 2008; 87(1): 8 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Giugliano, A. Ceriello, and K. Esposito Glucose metabolism and hyperglycemia Am. J. Clinical Nutrition, January 1, 2008; 87(1): 217S - 222S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. E. Praet and L. J. C. van Loon Optimizing the therapeutic benefits of exercise in Type 2 diabetes J Appl Physiol, October 1, 2007; 103(4): 1113 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Lien, A. J. Brown, J. D. Ard, C. Loria, T. P. Erlinger, A. C. Feldstein, P.-H. Lin, C. M. Champagne, A. C. King, H. L. McGuire, et al. Effects of PREMIER Lifestyle Modifications on Participants With and Without the Metabolic Syndrome Hypertension, October 1, 2007; 50(4): 609 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Emili, H. Abushomar, and K. Nair Treating metabolic syndrome: Lifestyle change or medication? Can Fam Physician, July 1, 2007; 53(7): 1203 - 1205. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF]
|
|
|
|
|
|
J. Waden, L. M. Thorn, C. Forsblom, T. Lakka, M. Saraheimo, M. Rosengard-Barlund, O. Heikkila, M. Wessman, J. A. Turunen, M. Parkkonen, et al. Leisure-Time Physical Activity Is Associated With the Metabolic Syndrome in Type 1 Diabetes: Effect of the PPAR{gamma} Pro12Ala polymorphism: the FinnDiane Study Diabetes Care, June 1, 2007; 30(6): 1618 - 1620. [Full Text] [PDF]
|
|
|
|
|
|
R. E Pratley and G. Matfin Review: Pre-diabetes: clinical relevance and therapeutic approach The British Journal of Diabetes & Vascular Disease, May 1, 2007; 7(3): 120 - 129. [Abstract] [PDF]
|
|
|
|
|
|
C. Y. Jeon, R. P. Lokken, F. B. Hu, and R. M. van Dam Physical Activity of Moderate Intensity and Risk of Type 2 Diabetes: A systematic review Diabetes Care, March 1, 2007; 30(3): 744 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Freemark Pharmacotherapy of Childhood Obesity: An evidence-based, conceptual approach Diabetes Care, February 1, 2007; 30(2): 395 - 402. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Abdul-Ghani, M. Matsuda, B. Balas, and R. A. DeFronzo Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test Diabetes Care, January 1, 2007; 30(1): 89 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Tice, A. Kanaya, T. Hue, S. Rubin, D. S. M. Buist, A. LaCroix, J. V. Lacey Jr, J. A. Cauley, S. Litwack, L. A. Brinton, et al. Risk Factors for Mortality in Middle-aged Women Arch Intern Med, December 11, 2006; 166(22): 2469 - 2477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Iribarren, A. S. Go, G. Husson, S. Sidney, J. M. Fair, T. Quertermous, M. A. Hlatky, and S. P. Fortmann Metabolic Syndrome and Early-Onset Coronary Artery Disease: Is the Whole Greater Than Its Parts? J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1800 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Page, J. K. Amory, B. D. Anawalt, M. S. Irwig, A. T. Brockenbrough, A. M. Matsumoto, and W. J. Bremner Testosterone Gel Combined with Depomedroxyprogesterone Acetate Is an Effective Male Hormonal Contraceptive Regimen and Is Not Enhanced by the Addition of a GnRH Antagonist J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4374 - 4380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Neville, R. J. Cohn, K. S. Steinbeck, K. Johnston, and J. L. Walker Hyperinsulinemia, Impaired Glucose Tolerance, and Diabetes Mellitus in Survivors of Childhood Cancer: Prevalence and Risk Factors J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4401 - 4407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J O'Loughlin, E Dugas, K Maximova, and N Kishchuk Reporting of ethnicity in research on chronic disease: update Postgrad. Med. J., November 1, 2006; 82(973): 737 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Griel, E. H. Ruder, and P. M. Kris-Etherton The Changing Roles of Dietary Carbohydrates: From Simple to Complex Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1958 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J Moran, M. Noakes, P. M Clifton, G. A Wittert, G. Williams, and R. J Norman Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome Am. J. Clinical Nutrition, July 1, 2006; 84(1): 77 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Davis, A. Emerenini, and J. Wylie-Rosett Obesity management: physician practice patterns and patient preference. The Diabetes Educator, July 1, 2006; 32(4): 557 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. A Carpentier, L. Portois, and W. J Malaisse n-3 Fatty acids and the metabolic syndrome Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1499 - 1504S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Esposito, M. Ciotola, D. Carleo, B. Schisano, F. Saccomanno, F. C. Sasso, D. Cozzolino, R. Assaloni, D. Merante, A. Ceriello, et al. Effect of Rosiglitazone on Endothelial Function and Inflammatory Markers in Patients With the Metabolic Syndrome Diabetes Care, May 1, 2006; 29(5): 1071 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. K. de Aguiar, L. R. Bahia, N. Villela, C. Laflor, F. Sicuro, N. Wiernsperger, D. Bottino, and E. Bouskela Metformin Improves Endothelial Vascular Reactivity in First-Degree Relatives of Type 2 Diabetic Patients With Metabolic Syndrome and Normal Glucose Tolerance Diabetes Care, May 1, 2006; 29(5): 1083 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Giugliano and K. Esposito Optimal Treatments for the Metabolic Syndrome Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): e30 - e30. [Full Text] [PDF]
|
|
|
|
|
|
K. Esposito and D. Giugliano Beneficial Effects of a Dietary Approaches to Stop Hypertension Eating Plan on Features of the Metabolic Syndrome: Response to Azdbakht et al. Diabetes Care, April 1, 2006; 29(4): 954 - 955. [Full Text] [PDF]
|
|
|
|
|
|
D. Giugliano and K. Esposito The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Kahn et al. Diabetes Care, January 1, 2006; 29(1): 175 - 176. [Full Text] [PDF]
|
|
|
|
 |
|
 R. J Sigal A lifestyle intervention or metformin prevented or delayed the onset of metabolic syndrome in persons at risk Evid. Based Med., December 1, 2005; 10(6): 172 - 172. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Dhahbi, P. L. Mote, G. M. Fahy, and S. R. Spindler Identification of potential caloric restriction mimetics by microarray profiling Physiol Genomics, November 17, 2005; 23(3): 343 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Anania, S. Parekh, and A. Shaukat The Diabetes Prevention Program and the Metabolic Syndrome Ann Intern Med, October 4, 2005; 143(7): 545 - 545. [Full Text] [PDF]
|
|
|
|
|
|
P. S. Sarinas and D. S. Dube The Diabetes Prevention Program and the Metabolic Syndrome Ann Intern Med, October 4, 2005; 143(7): 544 - 545. [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden 2nd International Symposium on Triglycerides and HDL: Metabolic syndrome Diabetes Care, October 1, 2005; 28(10): 2577 - 2584. [Full Text] [PDF]
|
|
|
|
 |
|
 Preventing Metabolic Syndrome by Preventing Diabetes DOC News, August 1, 2005; 2(8): 14 - 15. [Full Text]
|
|
|
|
|
|
Endocrinology & Metabolism News, June 2005 J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 16a - 16a. [Full Text] [PDF]
|
|
Read all Rapid Responses
| ||||||||||||||||||||||||||||||||||||||||||||||
Article
